Panacea Biotec (PANACEABIO)
FAST GROWERFairStock Score: 6/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹356.5 |
| Market Cap | ₹2,027.4 Cr |
| P/E Ratio | 0 |
| ROCE | -4.57% |
| ROE | -13.29% |
| Dividend Yield | 0% |
| Profit Growth | 32.57% |
| Debt/Equity | 0.03 |
| Sales Growth | 1.04% |
| Promoter Holding | 72.48% |
| 52-Week Range | ₹292.4 — ₹595 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹51.56 |
Panacea Biotec trades with ROCE of -4.57%, ROE of -13.29%, profit growth of 32.57%, debt-to-equity of 0.03. The FairStock Score of 6/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer